Heterocyclic compounds as CBP / EP300 bromodomain inhibitors

NZ836701APending Publication Date: 2026-09-25AURIGENE ONCOLOGY LIMITED

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: NZ836701
Authority / Receiving Office: NZ · NZ
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2020-09-09
Filing Date: 2021-09-09
Publication Date: 2026-09-25

Application Information

Patent Timeline

09 Sep 2020

Priority

09 Sep 2021

Application

NZ836701

25 Sep 2026

Publication

NZ836701A

IPC: A61K31/00; C07D401/14; A61P35/00; C07D471/04; C07D487/22

Inventors: ABBINENI, CHANDRASEKHAR; AGGUNDA RENUKAPPA, GIRISH

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention provides heterocyclic compounds of formula (I), which are therapeutically useful as CBP / EP300 inhibitors. These compounds are useful in the treatment and / or prevention of diseases or disorders mediated by CBP and / or EP300 in an individual. The present invention also provides preparation of the compounds and pharmaceutical compositions comprising at least one of the compounds of formula (I) or a pharmaceutically acceptable salt, or a stereoisomer or a tautomer, an N-oxide or an ester thereof.

Need to check novelty before this filing date? Find Prior Art